This post will be a little different from most here at the BiotechDueDiligence blog* - please let me know if you find this sort of information helpful, so that I know whether to post on additional topics in the future.
We here a great deal these days about biomarkers and their importance in drug discovery, clinical trials, and even regulatory paths to approval. I would like to highlight a few articles on the topic that were recently published in the journals Cancer Research and Clinical Cancer Research (continue reading below the jump)
*Inspiration and many more examples courtesy of the Biotech Strategy Blog (written by Pieter Droppert) and the Pharma Strategy Blog (authored by Dr. Sally Church).
We here a great deal these days about biomarkers and their importance in drug discovery, clinical trials, and even regulatory paths to approval. I would like to highlight a few articles on the topic that were recently published in the journals Cancer Research and Clinical Cancer Research (continue reading below the jump)
*Inspiration and many more examples courtesy of the Biotech Strategy Blog (written by Pieter Droppert) and the Pharma Strategy Blog (authored by Dr. Sally Church).
RSS Feed
